ALS (motor neurone disease) trials in Latvia

2 of 2 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Not yet taking people in Latvia
  Efficacy and Safety of Masitinib in Combination With SoC Versus Placebo in the Treatment of ALS Patients

  Where

  Riga

  Age

  18 years to 80 years

  People

  412 worldwide

  Run by

  AB Science

  See details and how to joinNCT07174492 · EU 2024-511244-12-01
• Phase 1Not yet taking people in Latvia
  A PHASE 1B, MULTICENTER, RANDOMIZED, PLACEBO- CONTROLLED, DOUBLE-BLIND STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND BIOLOGICAL ACTIVITY OF TQS-168 IN SUBJECTS WITH AMYOTROPHIC LATERAL SCLEROSIS

  Where

  Riga

  Age

  18 years and over

  People

  16

  Run by

  Tranquis Therapeutics Inc.

  See details and how to join2023-504746-54-00